Gore; Paul Martin
Patent Applications and Registrations
Patent applications and USPTO patent grants for Gore; Paul Martin.The latest application filed is for "pyrazole compounds acting against allergic, inflammatory and immune disorders".
- Gore; Paul Martin - Stevenage GB
- Gore; Paul Martin - Hertfordshire GB
- Gore; Paul Martin - Research Triangle Park NC
- Gore, Paul Martin - Stevenage Hertfordshire GB
| Patent | Date |
|---|---|
| Pyrazole compounds acting against allergic, immune and inflammatory conditions Grant 9,156,791 - Cooper , et al. October 13, 2 | 2015-10-13 |
| Pyrazole compounds acting against allergic, inflammatory and immune disorders Grant 9,149,462 - Cooper , et al. October 6, 2 | 2015-10-06 |
| Pyrazole Compounds Acting Against Allergic, Inflammatory And Immune Disorders App 20130217658 - Cooper; Anthony William James ; et al. | 2013-08-22 |
| Pyrazole Compounds Acting Against Allergic, Immune and Inflammatory Conditions App 20130203705 - Cooper; Anthony William James ; et al. | 2013-08-08 |
| N-pyrazolyl carboxamides as CRAC channel inhibitors Grant 8,399,436 - Allen , et al. March 19, 2 | 2013-03-19 |
| N-pyrazolyl Carboxamides As Crac Channel Inihibitors App 20120053150 - Allen; David George ; et al. | 2012-03-01 |
| Pyrazole And Triazole Carboxamides As Crac Chann El Inhibitors App 20120035237 - Coe; Diane Mary ; et al. | 2012-02-09 |
| Substituted Quinoline Derivatives As H1 Receptor Antagonists App 20110281909 - Gore; Paul Martin ; et al. | 2011-11-17 |
| Compounds Grant 7,884,114 - Gore , et al. February 8, 2 | 2011-02-08 |
| Compounds App 20100273744 - Gore; Paul Martin ; et al. | 2010-10-28 |
| Quinoline Derivatives Used To Treat Inflammatory And Allergic Diseases App 20100222349 - Gore; Paul Martin ; et al. | 2010-09-02 |
| Phthalazine And Pyrido[3,4-d]pyridazine Compounds As H1 Receptor Antagonists App 20100216799 - Gore; Paul Martin ; et al. | 2010-08-26 |
| Compounds App 20100184770 - Gore; Paul Martin ; et al. | 2010-07-22 |
| Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases Grant 7,622,464 - Ancliff , et al. November 24, 2 | 2009-11-24 |
| Compounds App 20090270355 - Gore; Paul Martin ; et al. | 2009-10-29 |
| 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists App 20090105225 - Gore; Paul Martin ; et al. | 2009-04-23 |
| Compounds App 20080039444 - GORE; Paul Martin ; et al. | 2008-02-14 |
| Novel Compounds App 20080004295 - Gore; Paul Martin ; et al. | 2008-01-03 |
| Compounds useful in the treatment of inflammatory diseases Grant 7,157,457 - Ancliff , et al. January 2, 2 | 2007-01-02 |
| Morpholin-acetamide derivatives for the treatment of inflammatory diseases Grant 7,101,882 - Ancliff , et al. September 5, 2 | 2006-09-05 |
| Morpholin-acetamide derivatives for the treatment of inflammatory diseases App 20060079525 - Ancliff; Rachael Anne ; et al. | 2006-04-13 |
| Novel compounds App 20060063765 - Ancliff; Rachael Ann ; et al. | 2006-03-23 |
| N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions App 20060058299 - Ancliff; Rachael Ann ; et al. | 2006-03-16 |
| Compounds useful in the treatment of inflammatory diseases Grant 6,867,192 - Armour , et al. March 15, 2 | 2005-03-15 |
| Morpholin-acetamide derivatives for the treatment of inflammatory diseases App 20040058923 - Ancliff, Rachael Anne ; et al. | 2004-03-25 |
| Compounds useful in the treatment of inflammatory diseases App 20040058907 - Ancliff, Rachael Anne ; et al. | 2004-03-25 |
| Novel aqueous anti-inflammatory pharmaceutical formulation App 20040044035 - Armour, Duncan Robert ; et al. | 2004-03-04 |
| Dry-powder pharmaceutical formulation for inhalation comprising alpha4-integrin antagonist App 20040037784 - Armour, Duncan Robert ; et al. | 2004-02-26 |
| Novel aqueous anti-inflammatory pharmaceutical formulation App 20040034062 - Armour, Duncan Robert ; et al. | 2004-02-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 